Clinical Trials
5 trialsNCT06662227 2026-05-07
Universal CAR-T Cells (REVO-UWD-19) for Refractory and Relapsed B-Cell Tumors
Wondercel Biotech (ShenZhen)
Phase EARLY_PHASE1 Suspended
NCT06824701 2026-04-06
TARZAN
University of Utah
Phase 1 Suspended
NCT04746131 2022-09-26
Safety and Pharmacokinetic Study of IMM0306 in Patients With Refractory or Relapsed CD20-positive B-cell Non-Hodgkin's Lymphoma (B-NHL)
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Phase 1 Suspended
NCT03704714 2022-08-15
Nivolumab and Combination Chemotherapy in Treating Participants With Diffuse Large B-Cell Lymphoma
Northwestern University
Phase 1/2 Suspended
NCT04697290 2022-02-14
CD19/CD20 Dual-CAR-T in B-cell Non-Hodgkin's Lymphoma Patients.
Beijing Tsinghua Chang Gung Hospital
Phase EARLY_PHASE1 Suspended